Skip to main content

Table 1 Patient’s characteristics

From: Functional and clinical significance of ROR1 in lung adenocarcinoma

Patient’s Characteristics no. (%)
Sex
 Male 26/56 (46.4%)
 Female 30/56 (53.6%)
Race
 Caucasian 56/56 (100%)
Stage of disease at diagnosis
 I/II/IIIA 52/56 (92.9%)
 IIIB/IV 4/56 (7.1%)
Histologic Type
 Adenocarcinoma 56/56 (100%)
Mutation present
 ROR1 16/56 (28.6%)
 EGFR 5/56 (8.9%)
 KRAS 26/56 (46.4%)
 ALK 1/9 (11.1%)
 BRAF 1/54 (1.9%)
 HER2 1/55 (1.8%)
 TTF-1 45/56 (80.3%)
 ROS1 0/45 (0%)
  1. Description of the clinicopathological features and of the mutational characterization of the cohort included in this study. Patient’s characteristics subgroups are reported in bold. Abbreviations: no number.
\